The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint

TIDES: Oligonucleotide and Peptide® Therapeutics from Research through Commercialization

CSS

Agenda CSS

Access the hottest fields in therapeutics by attending TIDES - the only event with full coverage of discovery, development and manufacturing

May 12-15, 2013
Hynes Convention Center
Boston, MA

Alt Language

Alternate Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese

Poster Presentations

Poster Presentations

TIDES 2013 Poster Presentations

Below is a list of the poster presentations accepted for display at TIDES 2013.

1 Effects of Capping on Peptide Purity Raymond Behrendt, Merck Millipore

2 Temperature- and Salt-independent Detection of Single Nucleotide Mismatch by Ultra-specific Hybridization Xi Chen, Harvard University

3 CMDpeptide: A Physics Driven Strategy for Predicting Peptide and Macrocycle Structure David Diller, CMD Bioscience

4 Charged Surface Hybrid C18 for High Resolution Peptide Analyses and Lab Scale Peptide Purifications Ananya Dubey, Waters Corp

5 Analysis of Drug Attachment Site Peptide: Implications for ADC Potency and Stability Robert Duff, Eurofins Lancaster Laboratories, Inc

6 Generating Aptamers as Molecular Probes for Targeting Inflamed Aortic Endothelial Cells Kaili Ji, National University of Singapore

7 Zinc Adduct Depot Systems for Long-Acting Peptide formulations Aadithya Krishnan, Pfizer, Inc

8 ANG2002: A New Brain-penetrant Angiopep-Neurotensin for the Treatment of Pain Alain Larocque, Angiochem Inc

9 Synthesis of Biologically Active Branched and Hyperbranch Oligonucleotides Anthony Maina, Seton Hall University

10 Improving the ADME Sample Preparation Bottleneck in Oligonucleotide Clinical Development Michael McGinley, Phenomenex

11 High-Purity Peptides with Minimal HPLC Purification Vittorio Montanari, Veraquel Technologies, Inc

12 Greater Loading Capacity and Resolution for Improved Process-Scale Peptide Purification Reno Nguyen, Grace

13 A New Tool for Solid Phase Synthesis and Extraction Hsing-Yeh Parker, PolyDesign, LLC

14 Development of a Scalable Process for CNP-22 Valerie Paulsen, Corden Pharma Colorado

15 Raw Material Control for the Manufacturing of Oligonucleotides - Example Siegmar Pulst, Digital Specialty Chemicals Limited

16 Application of TINA Modified Primers for Enhanced PCR Efficiency Yogesh Sanghvi, Rasayan Inc.

17 New Wide Pore Media Improves Loading Capacity and Productivity for Peptide Purification by Flash Chromatography Janine Sinck, Grace Discovery Sciences

18 Efficient Analysis and Cost-effective Purification of Peptides Using a Hybrid Based Reversed Phase Material Ernest Sobkow, YMC America, Inc.

19 Ugimers - New Chemistry to Expand the Therapeutic Gene Silencing Space Towards Immunological Applications Juergen Soutschek, Ugichem GmbH

20 NittoPhase®HL Solid Support - High Loaded Polymeric Solid Supports for Oligonucleotide Synthesis Kwok Yin Tsang, Kinovate Life Sciences, Inc.

21 Effect of Triazine Impurity in NMI Capping Reagent on Oligonucleotides Mohan Venkatram, Honeywell Burdick & Jackson

22 Immunoassays for the Determination of Peptide Therapeutics: Developmental Challenges. Simon Williams, Charles River

23 Solid-Phase Synthesis and Application of Carboxyrhodamine 6G Labeled Dual-Labeled Probes. Does the Best Dye for qPCR Exist? Timofey Zatsepin, Lomonosov Moscow State University